PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in PharmaCyte Biotech, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +1 vs. Q3 2022
- Shares held
- 3.39M
- −1.59M (−32.0%) vs. Q3 2022
- Total value
- $9.93M
- −$2.03M (−17.0%) vs. Q3 2022
- New holders
- 7
- 9 more added
- Sold out
- 6
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 98 | $0 | 0.00% | −53−35.1% | Reduced |
| CWM, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 2 | $0 | 0.00% | +2 | New |
| TCI Wealth Advisors, Inc. | 3 | $9 | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 3 | $9 | 0.00% | +3 | New |
| UBS Group AG | 9 | $27 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 27 | $79 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 55 | $161 | 0.00% | +24+77.4% | Added |
| Advisory Services Network, LLC | 67 | $196 | 0.00% | +67 | New |
| Bank of America Corp | 98 | $286 | 0.00% | +44+81.5% | Added |
| Wells Fargo & Company | 141 | $413 | 0.00% | +3+2.2% | Added |
| Kelly Financial Services LLC | 234 | $686 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 207 | $1.00K | 0.00% | +110+113.4% | Added |
| Aspire Private Capital, LLC | 800 | $2.34K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,758 | $6.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 11,984 | $35.1K | 0.00% | +836+7.5% | Added |
| Charles Schwab Investment Management Inc | 17,219 | $50.3K | 0.00% | +17,219 | New |
| Citadel Advisors LLC | 17,503 | $51.1K | 0.00% | +17,503 | New |
| Jane Street Group, LLC | 20,705 | $60.7K | 0.00% | +20,705 | New |
| Schonfeld Strategic Advisors LLC | 25,200 | $73.8K | 0.00% | +400+1.6% | Added |
| FNY Investment Advisers, LLC | 31,100 | $90.0K | 0.13% | +31,100 | New |
| Price T Rowe Associates Inc | 36,400 | $106.0K | 0.00% | −10,600−22.6% | Reduced |
| Northern Trust Corp | 37,619 | $110.2K | 0.00% | −110.0% | Reduced |
| Davy Global Fund Management Ltd | 40,800 | $119.5K | 0.02% | +2,029+5.2% | Added |
| State Street Corp | 62,600 | $182.8K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 63,608 | $186.0K | 0.01% | −1,812−2.8% | Reduced |
| Sabby Management, LLC | 97,978 | $287.1K | 0.77% | −469,622−82.7% | Reduced |
| Geode Capital Management, LLC | 175,264 | $511.0K | 0.00% | −343−0.2% | Reduced |
| Equitec Proprietary Markets, LLC | 330,694 | $968.9K | 0.57% | 00.0% | Unchanged |
| Vanguard Group Inc | 654,517 | $1.92M | 0.00% | +11,343+1.8% | Added |
| K2 Principal Fund, L.P. | 732,105 | $2.15M | 0.59% | +120,942+19.8% | Added |
| Ayrton Capital LLC | 1,033,130 | $3.03M | 8.29% | 00.0% | Unchanged |
| Shay Capital LLC | 0 | $0 | 0.00% | −1,015,666−100.0% | Sold out |
| Csenge Advisory Group | 0 | $0 | 0.00% | −200,104−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −75,052−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −25,018−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,624−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −7−100.0% | Sold out |